Company Overview
- Headquarters
- 84 Waterford Dr, Marlborough MA
- Website
- sunovion.com
- ka****@sunovion.com
- Phone
- (508) 481-6700
- Employees
- 1,046
- Founded in
- 2010
- Industry
- Materials/Manufacturing
- NAICS Code
-
NAICS Code 62151 CompaniesNAICS Code 3254 CompaniesNAICS Code 62 CompaniesNAICS Code 621 CompaniesNAICS Code 32 CompaniesNAICS Code 32541 CompaniesNAICS Code 6215 CompaniesNAICS Code 325 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$284B
Who is Sunovion Pharmaceuticals Inc
Sunovion Pharmaceuticals Inc. is a science-based, technology-driven biopharmaceutical company headquartered in Marlborough, Massachusetts. The company employs 1,046 people and generates $283.6 million in annual revenue. Sunovion focuses on developing and commercializing life-transforming treatments for serious neurological and psychiatric conditions. Their portfolio includes medications such as Latuda® (lurasidone HCI), Aptiom® (eslicarbazepine acetate), Lonhala® Magnair® (glycopyrrolate), and KYNMOBI® (apomorphine HCI) sublingual film. The company is committed to scientific excellence, meaningful advocacy, and relevant education to improve the lives of patients. Sunovion's dedication to research and development drives their innovation in the field of biopharmaceuticals. For more information, visit www.sunovion.com, or connect on Twitter and Facebook @Sunovion.
Company Leadership
Sunovion Pharmaceuticals Inc Industry Tags
Companies Similar to Sunovion Pharmaceuticals Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Sunovion Pharmaceuticals Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 280M | 2,265 | White Plains, NY | 1991 | |
| 277M | 200 | Clinton, IA | 1974 | |
| 273M | 345 | Stoughton, MA | 2002 | |
| 271M | 983 | O Fallon, MO | 1945 | |
| 270M | 276 | La Porte, IN | 1914 |